Xsolis is a technology company driven by artificial intelligence (AI) that fosters collaboration between health systems and health plans through real-time transparency and objective data. The result is increased accuracy and alignment of medical necessity decisions for more efficient outcomes. During the company’s 12-year history, Xsolis has generated more than 2.8 billion predictions to drive improvements in level of care authorizations, length-of-stay management, and payer-provider alignment for 500+ providers nationwide.
Dragonfly®, its AI-driven proprietary platform, synthesizes relevant clinical and financial data from the patient’s electronic medical record to build a clinical profile at the first point of encounter. Dragonfly then continuously evaluates the patient’s profile against a vast database of situationally relevant cases, identifying clinical patterns and generating highly precise predictive analytics to not only help determine the most appropriate level of care and length-of-stay timelines, but also improve clinical documentation and revenue integrity.
Xsolis provides comprehensive services to ensure efficient implementation of the platform, successful adoption by nurses and physicians, and positive impact to targeted key performance indicators. Physician advisor and denial services teams are on hand for second-level reviews, peer-to-peer services, and appeals, effectively relieving staff of these burdens. This proactive approach significantly reduces the cost of care, while ensuring every patient is in the right status at the right time.
For more information, visit the Xsolis website or contact Regional Sales Director West Doug Knolles at (602) 689-0330 or dknolles@xsolis.com.